EP2890397
Andprólaktín viðtakamótefnasamsetningar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.8.2013EP published:
19.6.2019EP application number:
13760180.3
EP translation filed:
14.8.2019Grant published:
15.9.2019EPO information:
European Patent Register
Max expiry date:
27.8.2033Expiry date:
27.8.2026Next due date:
31.8.2026
Title:
ANTI-PROLACTIN RECEPTOR ANTIBODY FORMULATIONS
Timeline
Today
28.8.2013EP application
19.6.2019EP Publication
14.8.2019Translation submitted
15.9.2019Registration published
27.8.2026Expires
Owner
Name:
Bayer HealthCare LLCAddress:
100 Bayer Boulevard, 07981-0915, Whippany, NJ, US
Inventor
Name:
MA, XinghangAddress:
Dublin, CA, US
Name:
XIANG, JunAddress:
Pleasant Hill, CA, US
Name:
NIU, JianjieAddress:
Castro Valley, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261695949 PDate:
31.8.2012Country:
US
Number:
201313842906Date:
15.3.2013Country:
US
Classification
Categories:
A61K 39/395, C07K 16/28, A61P 5/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 23.7.2019
Expires: 27.8.2020
Payer: Árnason Faktor
Number: 8
Paid: 24.7.2020
Expires: 27.8.2021
Payer: Árnason Faktor ehf.
Number: 9
Paid: 23.7.2021
Expires: 27.8.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 27.7.2022
Expires: 27.8.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 25.7.2023
Expires: 27.8.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 23.7.2024
Expires: 27.8.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 5.8.2025
Expires: 27.8.2026
Payer: Árnason Faktor ehf.